News about Global Pharma

IndiaRF to Acquire API and CRAMS Business of Ind-Swift Laboratories Limited Worth INR 1,650 Crores

Ind-Swift is amongst the top ten independent merchant API businesses in India in size, with two manufacturing sites in Punjab and Jammu, and a combined reactor capacity of ~700 KL catering to both regulated and unregulated markets.

Global Pharma | 08/09/2023 | By Manvi |  729

Schott Seeks More than USD 860 Million in Pharma Unit IPO

Schott Pharma announced plans for a stock sale, consisting of existing shares held by its parent, which will remain the majority shareholder.

Global Pharma | 07/09/2023 | By Manvi |  1209

Swissport Expands Pharma Network to Toronto

Swissport's cargo facilities at Liège Airport (LGG) in Belgium and Toronto Pearson International Airport (YYZ) in Canada have received IATA's CEIV Pharma certification, the company's 16th and 17th pharma warehousing certifications, respectively.

Global Pharma | 06/09/2023 | By Manvi |  944

SOMAI Pharmaceuticals Receives EU-GMP Certification at Lisbon Facility

SOMAÍ also announced that it had raised €5 million to fund its activities.

Global Pharma | 06/09/2023 | By Manvi |  1144

Element Unveils Fully Integrated Pharma Services Platform

The strategic initiative brings together the capabilities of its recent North American acquisitions of Nanosyn and JMI labs into its existing life sciences business.

Global Pharma | 06/09/2023 | By Manvi |  826

Enzene Biosciences Inaugrates R&D Centre with Open Lab Setup in Pune

Enzene Biosciences Ltd. announced the inauguration of its research and development (R&D) facility in Pune.

Global Pharma | 05/09/2023 | By Manvi |  1049

Cipla Medpro South Africa Pty Ltd to Acquire Actor Pharma

This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities and leverage cost synergies in the South African market.

Global Pharma | 05/09/2023 | By Manvi |  668

Caplin Steriles Gets Establishment Inspection Report from US FDA

The unit underwent an inspection from US FDA and the inspection classification was determined by the agency as Voluntary Action Indicated (VAI).

Global Pharma | 05/09/2023 | By Manvi |  1070

Nottingham Researchers Gets Major Funds for Sustainable Pharma Manufacturing

Researchers from the University of Nottingham have joined forces with biotechnology company HydRegen for a project that will unlock sustainable biocatalytic hydrogenation – allowing the process to be scaled up and improved for industry use.

Global Pharma | 04/09/2023 | By Manvi |  666

Shilpa Pharma Lifesciences Ltd, Unit II Cleares GMP inspection by PMDA in Karnataka

The facility is involved in manufacturing various oncology and non?oncology APIs.

Global Pharma | 04/09/2023 | By Manvi |  1700